HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.

Abstract
We studied a novel restriction fragment length polymorphism (RFLP) of the proto-oncogenes ETS-1 that we detected in a patient with an acute monocytic leukemia by the presence of two, 3.7 and 10 kb, Xbal fragments on Southern blots of DNA from blast cells and remission blood samples. RFLP analysis of a series of 114 normal donors revealed that only four (3.6%) shared the 10 kb fragment. By contrast, this unusual allele was found in 20 (all lymphocytic or monocytic) of 108 (18.5%) hematological malignancies (p less than 0.001). DNA sequence analysis indicated the disappearance in the rare allele of a Xbal site due to a single point mutation at the 3' end of ETS-1 locus. Molecular consequences of this mutation point to a possible pathogenic involvement of ETS-1 in these disorders and to the question of genetic susceptibility to hematological malignancies.
AuthorsJ P Kerckaert, M Duterque-Coquillaud, M Collyn-d'Hooghe, P Morel, M A Majérus, J L Laï, P Fenaux, F Bauters, B Debuire, M H Loucheux-Lefebvre
JournalLeukemia (Leukemia) Vol. 4 Issue 1 Pg. 16-9 (Jan 1990) ISSN: 0887-6924 [Print] England
PMID1967322 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ETS1 protein, human
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • RNA, Messenger
  • Transcription Factors
  • DNA
Topics
  • Anemia, Refractory, with Excess of Blasts (genetics)
  • Base Sequence
  • DNA (analysis)
  • Humans
  • Leukemia (genetics)
  • Molecular Sequence Data
  • Polymorphism, Restriction Fragment Length
  • Proto-Oncogene Mas
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins c-ets
  • Proto-Oncogenes
  • RNA, Messenger (analysis)
  • Transcription Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: